Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months | Zendy

Amy Sarah Ginsburg | Zendy; Tisungane Mvalo | Zendy; Evangelyn Nkwopara | Zendy; Eric D. McCollum | Zendy; Chifundo Ndamala | Zendy; Robert H. Schmicker | Zendy; Ajib Phiri | Zendy; Norman Lufesi | Zendy; Rasa Izadnegahdar | Zendy; Susanne May | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months

Author(s) -

Amy Sarah Ginsburg,

Tisungane Mvalo,

Evangelyn Nkwopara,

Eric D. McCollum,

Chifundo Ndamala,

Robert H. Schmicker,

Ajib Phiri,

Norman Lufesi,

Rasa Izadnegahdar,

Susanne May

Publication year - 2018

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2018.3407

Subject(s) - medicine , amoxicillin , placebo , pneumonia , randomized controlled trial , population , pediatrics , antibiotics , alternative medicine , environmental health , pathology , microbiology and biotechnology , biology

Pneumonia is the leading infectious killer of children. Rigorous evidence supporting antibiotic treatment of children with nonsevere fast-breathing pneumonia in low-resource African settings is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research